1. Novel hormone treatment of benign metastasizing leiomyoma: an analysis of five cases and literature review 
Erin I. Lewis, M.D., Rebecca J. Chason, M.D., Alan H. DeCherney, M.D., Alicia Armstrong, M.D., John Elkas, M.D., Aradhana M. Venkatesan, M.D. 
Fertility and Sterility 
Volume 99, Issue 7, Pages (June 2013)
DOI: /j.fertnstert
Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

2. Figure 1 ER/PR receptor status of BML case reports, 1986–2012.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

3. Figure 2
Tumor burden measured by RECIST 1.1 (19). (A1) Axial contrast-enhanced CT of the pelvis for case 1 pretreatment, March (A2) Axial contrast enhanced CT of the pelvis for case 1 post-treatment, January 2010—stable disease (9.2% decrease). (B1) Axial T2 weighted MRI of the pelvis for case 2 pretreatment, October (B2) Axial T2 weighted MRI of the pelvis for case 2 post-treatment, February 2008—stable disease (22.0% decrease). (C1) Axial fat suppressed contrast-enhanced MRI of the pelvis for case 3 pretreatment, February (C2) Axial fat suppressed contrast-enhanced MRI of the pelvis for case 3 post-treatment, August 2009—stable disease (20.4% decrease). (D1) Axial contrast–enhanced CT of the pelvis for case 4 pretreatment, November (D2) Axial contrast-enhanced CT of the pelvis for case 4 post-treatment, February 2008—stable disease (3.6% decrease). (E1) Axial T2 weighted MRI of the pelvis for case 5 pretreatment, June (E2) Axial T2 weighted MRI of the pelvis for case 5 post-treatment, September 2011—progressive disease (44.3% progression).
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions